HCA
USNA icon

Harbor Capital Advisors’s Usana Health Sciences USNA Stock Holding History

Harbor Capital Advisors’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7K Sell
387
-7,128
-95% -$141K ﹤0.01% 1067
2025
Q4 		$148K Buy
7,515
+1,216
+19% +$25.2K 0.01% 658
2025
Q3 		$174K Sell
6,299
-376
-6% -$11.6K 0.01% 612
2025
Q2 		$204K Sell
6,675
-320
-5% -$9.09K 0.01% 605
2025
Q1 		$189K Sell
6,995
-879
-11% -$27.8K 0.01% 618
2024
Q4 		$283K Sell
7,874
-985
-11% -$36.8K 0.01% 622
2024
Q3 		$336K Buy
8,859
+2,713
+44% +$111K 0.01% 623
2024
Q2 		$278K Sell
6,146
-3,047
-33% -$140K 0.02% 618
2024
Q1 		$446K Buy
9,193
+2,911
+46% +$143K 0.06% 426
2023
Q4 		$337K Buy
6,282
+1,547
+33% +$78.2K 0.06% 300
2023
Q3 		$278K Sell
4,735
-130
-3% -$8.13K 0.06% 317
2023
Q2 		$307K Buy
+4,865
New +$310K 0.06% 317

Other funds holding USNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Harbor Capital Advisors's USNA Position: Q1 2026 in Review

Harbor Capital Advisors reduced its Usana Health Sciences (USNA) stake by 95% in Q1 2026, selling an estimated $141K and leaving 387 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #1067.

Harbor Capital Advisors first reported a position in USNA in Q2 2023 and has held it in 12 quarters since. The position peaked at $446K in Q1 2024. 139 funds tracked by Wall St. Rank hold USNA as of Q1 2026.

  • Harbor Capital Advisors held 387 shares of Usana Health Sciences worth $7K as of Q1 2026.
  • Harbor Capital Advisors sold 7,128 Usana Health Sciences shares in Q1 2026, an estimated $141K.
  • Usana Health Sciences made up ﹤0.01% of Harbor Capital Advisors's portfolio in Q1 2026, its #1067 holding.
  • Harbor Capital Advisors first reported a position in Usana Health Sciences in Q2 2023 and has held it in 12 quarters since.
  • Harbor Capital Advisors's Usana Health Sciences position peaked at $446K in Q1 2024.
  • 139 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2026.

Based on Harbor Capital Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.